Sitemap
- Home
- About Us
- EQA/PT Programmes
- Trial Schedules
- New Participant Information
- Flow Cytometry Programmes
- CD34+ Stem Cell Enumeration (Accredited)
- Immune Monitoring (Accredited)
- Leukaemia Diagnostic Interpretation (Part 2) (Accredited)
- Leukaemia Immunophenotyping (Part 1) (Accredited)
- Low Level Leucocyte Enumeration (Accredited)
- *Measurable Residual Disease for ALL by Flow Cytometry (Accredited)
- *Paroxysmal Nocturnal Haemoglobinuria (Accredited)
- Cerebrospinal Fluid (CSF) Immunophenotyping (Pilot - Not Accredited)
- Haematological Malignancy Bone Marrow Aspirate Assessment (Pilot - Not Accredited)
- Measurable Residual Disease for AML by Flow Cytometry (Pilot - Not Accredited)
- *Measurable Residual Disease for CLL by Flow Cytometry (Pilot - Not Accredited)
- *Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (Pilot - Not Accredited)
- Competency Assessment and Instrument Validation Panel for Immune Monitoring
- Molecular Haemato-Oncology Programmes
- *BCR::ABL1 and AML Translocation Identification (Accredited)
- BCR::ABL1 Kinase Domain Variant (Mutation) Status (Accredited)
- BCR::ABL1 Major Quantification (Accredited)
- BCR::ABL1 Minor Quantification (Accredited)
- BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia (Accredited)
- *FLT3 Mutation Status (Accredited)
- IG/TCR Clonality Status (Accredited)
- JAK2 p.Val617Phe (V617F) Mutation Status (Accredited)
- KIT p.Asp816Val (D816V) Mutation Status for Mast Cell Disease (Accredited)
- NPM1 Mutation Status (Accredited)
- Paediatric Acute Leukaemia Translocations (Accredited)
- Post-Stem Cell Transplant Chimerism Monitoring (Accredited)
- Lymphoid Gene Panels (Pilot - Not Accredited)
- Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinaemia (Pilot - Not Accredited)
- Myeloid Gene Panels (Pilot - Not Accredited)
- *Myeloproliferative Neoplasms Diagnostic Testing (Pilot - Not Accredited)
- *Measurable Residual Disease for AML by Molecular Methods (Pilot - Not Accredited)
- *Measurable Residual Disease for Lymphoid Neoplasms by Molecular Methods (Pilot - Not Accredited)
- News/Events
- Contact us
Print
Sitemap
Follow Us Online
Facebook Twitter LinkedIn Youtube
Last updated 28/11/2023 © UK NEQAS for Leucocyte Immunophenotyping not to be reproduced in all or part without permission.
This website uses cookies. For more information please click here.
Please click here for our privacy policy.
The UK NEQAS Organisation is a Company Limited by Guarantee (No.3012351) and a Registered UK Charity (No.1044013).